Investigation of Risk Factors Linked to Bloodstream Infections from Candida parapsilosis in Children and Factors Influencing Fluconazole Resistance: A 15-Year Retrospective Cohort Study - Summary - MDSpire
Advertisement
Investigation of Risk Factors Linked to Bloodstream Infections from Candida parapsilosis in Children and Factors Influencing Fluconazole Resistance: A 15-Year Retrospective Cohort Study
To assess the incidence, epidemiological characteristics, and risk factors of candidemia caused by C.parapsilosis, and to determine the risk factors for fluconazole non-susceptibility and its impact on clinical outcomes, particularly in relation to treatment efficacy.
Key Findings:
C. parapsilosis is the second most prevalent cause of candidemia in children, highlighting the need for targeted treatment strategies.
Fluconazole resistance rates for C. parapsilosis have reached > 40-60% in some settings, raising concerns for treatment efficacy.
Identifying clinical risk factors for fluconazole resistance may guide empirical therapy and improve patient outcomes.
Interpretation:
The study highlights the increasing prevalence of C. parapsilosis in pediatric candidemia and the significant rates of fluconazole resistance, necessitating further investigation into risk factors and treatment strategies to enhance clinical management.
Limitations:
Retrospective design may introduce bias.
Limited generalizability due to single-center study.
Exclusion of neonates and preterm infants may affect findings and limit understanding of candidemia in these vulnerable populations.
Conclusion:
The findings underscore the need for ongoing surveillance of C. parapsilosis infections and fluconazole resistance in pediatric populations to inform treatment protocols.
